Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.180
-0.260 (-5.86%)
Apr 24, 2026, 12:58 PM EDT - Market open
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $217.02 million as of April 24, 2026. Its market cap has increased by 366.36% in one year.
Market Cap
217.02M
Enterprise Value
110.55M
1-Year Change
366.36%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $217.02M, an increase of 4.06%. That is a compound annual growth rate of 2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 230.52M | -27.52% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 240.78M |
| Arcturus Therapeutics Holdings | 240.74M |
| Sol-Gel Technologies | 236.45M |
| Replimune Group | 235.33M |
| Nuvectis Pharma | 232.86M |
| Fennec Pharmaceuticals | 230.29M |
| Milestone Pharmaceuticals | 229.35M |
| Codexis | 228.99M |